|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
21 August 2023 |
|
Main ID: |
NCT02223767 |
|
Date of registration:
|
20/08/2014 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
TMS Augmented Exposure Therapy
BEAT |
|
Scientific title:
|
Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment of Height Phobics |
|
Date of first enrolment:
|
August 2014 |
|
Target sample size:
|
47 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/ct2/show/NCT02223767 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Germany
| | | | | | | |
|
Contacts
|
|
Name:
|
Martin J. Herrmann, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Würzburg |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
Criteria for a simple phobia: specific heights
Exclusion Criteria:
Objective tinnitus Involvement in psychiatric treatments Clinically relevant psychiatric
comorbidity Clinically relevant unstable internal or neurological comorbidity History of or
evidence of significant brain malformation or neoplasm, head injury Cerebral vascular
events Neurodegenerative disorder affecting the brain or prior brain surgery Metal objects
in and around body that can not be removed Pregnancy Alcohol or drug abuse history of
seizures
Age minimum:
18 Years
Age maximum:
65 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Phobia
|
|
Intervention(s)
|
|
Device: Experimental: Verum TMS
|
|
Device: Experimental: Sham TMS
|
|
Primary Outcome(s)
|
|
Subjective Anxiety in Height Situation (BAT), Differences From Pre (Baseline) to Post Therapy (Week 4)
[Time Frame: 4 weeks]
|
|
Subjective Anxiety Symptoms
[Time Frame: 4 weeks]
|
|
Secondary ID(s)
|
|
098_MH
|
|
Wuerzburg177/12
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|